Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy

Digestive and Liver Disease

Volumn 45, Issue 8, 2013, Pages 687-691

  Bouvier, Anne Marie ^a,b   Minicozzi, Pamela ^c   Grosclaude, Pascale ^b   Bouvier, Véronique ^b   Faivre, Jean ^a,b   Sant, Milena ^c  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b FRANCIM (French Network of Cancer Registries)   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant chemotherapy; Cancer registry; Colon cancer; Stage II and III

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; COLON CANCER; DATA BASE; FEMALE; FRANCE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADJUVANT CHEMOTHERAPY; CANCER REGISTRY; COLON CANCER; STAGE II AND III;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84881542836     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.12.019     Document Type: Article

References (18)

1. Sant M., Allemani C., Santaquilani M., et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. European Journal of Cancer 2009, 45:931-991.
2. Van Cutsem E.J., Kataja V.V. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Annals of Oncology 2005, 16:i16-i17.
3. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators. Journal of Clinical Oncology 1999, 17:1349-1355.
4. Benson A., Schrag D., Somerfield M., et al. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. Journal of Clinical Oncology 2004, 22:3408-3419.
5. Crocetti E., Buzzoni C. New incidence and mortality data. 2003-2005. Epidemiologia e Prevenzione 2009, 33:e1-e3. e5-26.
6. Sobin L.H., Wittekind Ch. International Union Against Cancer (UICC). TNM classification of malignant tumors 1997, John Wiley & Sons, Inc, New York. 5th edition.
7. Haller D.G., Catalano P.J., Macdonald J.S., et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Journal of Clinical Oncology 2005, 23:8671-8678.
8. Newcomb P.A., Carbone P.P. Cancer treatment and age: patient perspectives. Journal of the National Cancer Institute 1993, 85:1580-1584.
9. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New England Journal of Medicine 1990, 322:352-358.
10. Faivre-Finn C., Bouvier A.M., Mitry E., et al. Chemotherapy for colon cancer in a well-defined French population: is it under- or over-prescribed?. Alimentary Pharmacology and Therapeutics 2002, 16:353-359.
11. Mahoney T., Kuo Y.H., Topilow A., et al. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Archives of Surgery 2000, 135:182-185.
12. Bouvier A.M., Jooste V., Bonnetain F., et al. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study. Cancer 2008, 113:879-886.
13. Sargent D.J., Goldberg R.M., Jacobson S.D., et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. New England Journal of Medicine 2001, 345:1091-1097.
14. Popescu R.A., Norman A., Ross P.J., et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. Journal of Clinical Oncology 1999, 17:2412-2418.
15. Bouvier A.M., Bauvin E.R., Danzon A., et al. Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000. Gastroenterologie Clinique et Biologique 2007, 31:286-291.
16. Sundararajan V., Mitra N., Jacobson J.S., et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Annals of Internal Medicine 2002, 136:349-357.
17. Ayanian J.Z., Zaslavsky A.M., Fuchs C.S., et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. Journal of Clinical Oncology 2003, 21:1293-1300.
18. Potosky A.L., Harlan L.C., Kaplan R.S., et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. Journal of Clinical Oncology 2002, 20:1192-1202.